Le Lézard
Classified in: Covid-19 virus
Subjects: Product/Service, Economic News/Analysis, Bond/Stock Rating

Best's Review Looks Ahead at New Year Fraught With Inflation and Other Challenges


The December issue of Best's Review examines issues that insurers are preparing for in 2023, with inflation as one of their top concerns:

Also included in the December issue:

Beginning in January, Best's Review's online magazine will move to a new, interactive format.

Best's Review is AM Best's monthly insurance magazine, covering emerging issues and trends and evaluating their impact on the marketplace. Access to the complete content of Best's Review is available here.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2022 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED.


These press releases may also interest you

at 07:15
Phase 2 data demonstrated positive immune responses to A and B strains, with acceptable safety and reactogenicity profile, meeting all pre-defined study endpointsVaccine candidate based on CureVac's proprietary second-generation mRNA backboneGSK...

at 07:00
Focused on Return to Profitability: 18.3% reduction in net loss to $6.8 million in the first nine months of 2024, down from $8.3 million in the same period of 2023; achieved 50.6% improvement over 2022, demonstrating strong commitment to reducing...

at 06:55
Signet Jewelers Limited ("Signet" or the "Company") , the world's largest retailer of diamond jewelry, today announced its results for the 13 weeks ended August 3, 2024 ("second quarter Fiscal 2025"). "I'd like to thank our Signet team for...

at 06:05
MYT Netherlands Parent B.V. ("Mytheresa" or the "Company") today announced financial results for its fourth quarter and full fiscal year 2024 ended June 30, 2024. The luxury multi-brand digital platform reported strong financial performance for the...

at 06:00
Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID combination vaccine for approval in 2024Announces positive Phase 3 results for its RSV vaccine for high-risk...

at 05:45
The Gross Law Firm issues the following notice to shareholders of ZoomInfo Technologies Inc. . Shareholders who purchased shares of...



News published on and distributed by: